Wedge Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.86M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $248K | Buy |
|
|||||
|
2022
Q4 | $257K | Buy |
|
|||||
|
2022
Q3 | $129K | Sell |
|
|||||
|
2022
Q2 | $117K | Buy |
|
|||||
|
2022
Q1 | $132K | Sell |
|
|||||
|
2021
Q4 | $144K | Sell |
|
|||||
|
2021
Q3 | $125K | Buy |
|
|||||
|
2021
Q2 | $100K | Sell |
|
|||||
|
2021
Q1 | $129K | Sell |
|
|||||
|
2020
Q4 | $631K | Buy |
|
|||||
|
2020
Q3 | $369K | Sell |
|
|||||
|
2020
Q2 | $585K | Buy |
|